A randomized, double-blind, placebo-controlled, multicenter, phase II study of senaparib maintenance therapy in post-docetaxel patients with metastatic castration-resistant prostate cancer (mCRPC) harboring alterations in homologous recombination repair (HRR) genes.
Senaparib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: A randomized, double-blind, placebo-controlled, multicenter, phase II study of senaparib maintenance therapy in post-docetaxel patients with metastatic castration-resistant prostate cancer (mCRPC) harboring alterations in homologous recombination repair (HRR) genes. ### Output: Senaparib